product summary
Loading...
company name :
R&D Systems
product type :
protein
product name :
Recombinant Human IFN-alpha B2 (alpha 8) Protein
catalog :
11115-1
quantity :
100000 UN
price :
480 USD
more info or order :
citations: 2
Reference |
---|
Liu Q, Tomei S, Ascierto M, De Giorgi V, Bedognetti D, Dai C, et al. Melanoma NOS1 expression promotes dysfunctional IFN signaling. J Clin Invest. 2014;124:2147-59 pubmed
|
product information
master code :
11115-1
SKU :
11115-1
product name :
Recombinant Human IFN-alpha B2 (alpha 8) Protein
unit size :
100000 UN
description :
The Recombinant Human IFN-alpha B2 (alpha 8) Protein from R&D Systems is derived from E. coli.
target :
IFN-alpha B2/IFNA8
category :
Proteins and Enzymes
conjugate :
Unconjugated
species :
Human
gene symbol :
IFNA8
source short :
E. coli
USD :
480 USD
alt names :
IFNA8, IFNalpha B2, IFN-alpha B2, IFN-alpha-8, IFN-alphaB, interferon alpha type 201, interferon alpha-8, interferon alpha-B', Interferon alpha-B, Interferon alpha-B2, interferon, alpha 8, LeIF B
storage :
Store the unopened product at -20 to -70 ░C. Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Do not use past expiration date.
more info or order :
company information

R&D Systems
614 McKinley Place N.E.
Minneapolis, MN 55413
Minneapolis, MN 55413
info@RnDSystems.com
https://www.rndsystems.com800 343-7475
headquarters: USA
R&D Systems develops and manufactures high-quality proteins and serves as a world leader in immunoassays. R&D Systems also produces quality antibodies, antibody arrays, stem cell and cell culture products, and cell selection and detection products, serving the life science and diagnostics industry.
related products
browse more products
- Recombinant Mouse gAdiponectin/gAcrp30 Protein, CF | 1119-AC-025
- Recombinant Human ROBO2 Fc Chimera Protein, CF | 3147-RB-050
- Recombinant Human Matrilin-2 Protein, CF | 3044-MN-050/CF
- Recombinant Mouse DNER Fc Chimera Protein, CF | 2254-DN-050
- Recombinant Human Noggin Fc Chimera GMP Protein, CF | 3344-GMP-050
questions and comments